These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1673395)

  • 1. Identification of major metabolites of the catechol-O-methyltransferase-inhibitor nitecapone in human urine.
    Taskinen J; Wikberg T; Ottoila P; Kanner L; Lotta T; Pippuri A; Bäckström R
    Drug Metab Dispos; 1991; 19(1):178-83. PubMed ID: 1673395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of major metabolites of the catechol-O-methyltransferase inhibitor nitecapone in the rat and dog.
    Wikberg T; Taskinen J
    Drug Metab Dispos; 1993; 21(2):325-33. PubMed ID: 8097704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of major metabolites of the catechol-O-methyltransferase inhibitor entacapone in rats and humans.
    Wikberg T; Vuorela A; Ottoila P; Taskinen J
    Drug Metab Dispos; 1993; 21(1):81-92. PubMed ID: 8095232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolite profiles of two [14C]-labelled catechol O-methyltransferase inhibitors, nitecapone and entacapone, in rat and mouse urine and rat bile.
    Wikberg T; Vuorela A
    Eur J Drug Metab Pharmacokinet; 1994; 19(2):125-35. PubMed ID: 8001593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of major urinary metabolites of the catechol-O-methyltransferase inhibitor entacapone in the dog.
    Wikberg T; Ottoila P; Taskinen J
    Eur J Drug Metab Pharmacokinet; 1993; 18(4):359-67. PubMed ID: 8020535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme-assisted synthesis and structural characterization of nitrocatechol glucuronides.
    Luukkanen L; Kilpeläinen I; Kangas H; Ottoila P; Elovaara E; Taskinen J
    Bioconjug Chem; 1999; 10(1):150-4. PubMed ID: 9893978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural characterization of urinary metabolites of the antiarrhythmic drug encainide in human subjects.
    Jajoo HK; Mayol RF; LaBudde JA; Blair IA
    Drug Metab Dispos; 1990; 18(1):28-35. PubMed ID: 1970774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.
    Dow J; Piriou F; Wolf E; Dulery BD; Haegele KD
    Drug Metab Dispos; 1994; 22(5):738-49. PubMed ID: 7835226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of nitecapone and (13C6)nitecapone in human plasma by gas chromatography/mass spectrometry.
    Ottoila P; Pakkala E; Karlsson C; Taskinen J
    Biol Mass Spectrom; 1991 Dec; 20(12):771-6. PubMed ID: 1812986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of a catechol-O-methyltransferase inhibitor, nitecapone, in human plasma and urine by liquid chromatography.
    Wikberg T; Taskinen J
    J Pharm Biomed Anal; 1991; 9(1):59-64. PubMed ID: 2043724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catechol estrogen 4-hydroxyequilenin is a substrate and an inhibitor of catechol-O-methyltransferase.
    Yao J; Li Y; Chang M; Wu H; Yang X; Goodman JE; Liu X; Liu H; Mesecar AD; Van Breemen RB; Yager JD; Bolton JL
    Chem Res Toxicol; 2003 May; 16(5):668-75. PubMed ID: 12755597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and identification of seven glucuronide conjugates of andrographolide in human urine.
    Cui L; Qiu F; Yao X
    Drug Metab Dispos; 2005 Apr; 33(4):555-62. PubMed ID: 15644451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the metabolites of the HIV-1 reverse transcriptase inhibitor delavirdine in monkeys.
    Chang M; Sood VK; Kloosterman DA; Hauer MJ; Fagerness PE; Sanders PE; Vrbanac JJ
    Drug Metab Dispos; 1997 Jul; 25(7):814-27. PubMed ID: 9224776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isolation and identification of some metabolites of phenyramidol (Cabral) from human urine (author's transl)].
    Goenechea S; Eckhardt G; Goebel KJ
    J Clin Chem Clin Biochem; 1977 Sep; 15(9):489-98. PubMed ID: 925636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of (-)-epicatechin metabolites and their metabolic fate in the rat.
    Okushio K; Suzuki M; Matsumoto N; Nanjo F; Hara Y
    Drug Metab Dispos; 1999 Feb; 27(2):309-16. PubMed ID: 9929521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and identification of major metabolites of tixocortol pivalate in human urine.
    Chanoine F; Grenot C; Sellier N; Barrett WE; Thompson RM; Fentiman AF; Nixon JR; Goyer R; Junien JL
    Drug Metab Dispos; 1987; 15(6):868-76. PubMed ID: 2893715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human metabolism of nebicapone (BIA 3-202), a novel catechol-o-methyltransferase inhibitor: characterization of in vitro glucuronidation.
    Loureiro AI; Bonifácio MJ; Fernandes-Lopes C; Almeida L; Wright LC; Soares-Da-Silva P
    Drug Metab Dispos; 2006 Nov; 34(11):1856-62. PubMed ID: 16790555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
    Prakash C; Cui D
    Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catechol metabolites of polychlorinated biphenyls inhibit the catechol-O-methyltransferase-mediated metabolism of catechol estrogens.
    Garner CE; Burka LT; Etheridge AE; Matthews HB
    Toxicol Appl Pharmacol; 2000 Jan; 162(2):115-23. PubMed ID: 10637135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The equine metabolism of the catechol-O-methyltransferase enzyme inhibitor nitecapone.
    Stanley S; Deng D; Van den Berg K; Foo HC
    Drug Test Anal; 2022 May; 14(5):929-935. PubMed ID: 34545698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.